The greatest therapeutic success so far has been in multiple myeloma using CD38 inhibitors as an antibody-based therapy to target white blood cells in the bone marrow that cause the disease and where CD38 is found on the cell surface. The gene discussed is CD38; the disease is AL amyloidosis.